The Ohio State University, OH
Dr. Peixuan Guo received his Ph.D. in Microbiology and Genetics with training in biophysics from the University of Minnesota in 1987. He was a postdoc at NIH before joining Purdue University as an assistant professor in 1990, tenured in 1993, full Professor in 1997, and was honored as a Purdue Faculty Scholar in 1998. He founded two Interdisciplinary Graduate Programs and established a NIH Nanomedicine Development Center at Purdue. He was recruited to University of Cincinnati as the Dane & Mary Louise Miller Endowed Chair of Biomedical Engineering in 2007, and was Director of the NIH Nanomedicine Development Center relocated from Purdue to University of Cincinnati. He moved to University of Kentucky as William Farish Endowed Chair in Nanobiotechnology in 2012, and was the UK Director of Nanobiotechnology Center.
In Jan 2016, he joined The Ohio State University College of Pharmacyas the first Sylvan G. Frank Endowed Chair in Pharmaceutics and Drug Delivery Systems. He was recruited in collaboration with Ohio State’s Dorothy M. Davis Heart and Lung Research Institute (DHLRI) and will hold a joint appointment in the College of Medicine’s Department of Physiology & Cell Biology. He is also currently the Director of NCI Cancer Nanotechnology Platform Partnership Program in RNA Nanotechnology for Cancer Therapy, and the Director of Center for RNA Nanobiotechnology and Nanomedicine.